Your browser doesn't support javascript.
loading
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers.
Drilon, Alexander; Lin, Jessica J; Filleron, Thomas; Ni, Ai; Milia, Julie; Bergagnini, Isabella; Hatzoglou, Vaios; Velcheti, Vamsidhar; Offin, Michael; Li, Bob; Carbone, David P; Besse, Benjamin; Mok, Tony; Awad, Mark M; Wolf, Jurgen; Owen, Dwight; Camidge, D Ross; Riely, Gregory J; Peled, Nir; Kris, Mark G; Mazieres, Julien; Gainor, Justin F; Gautschi, Oliver.
Afiliação
  • Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address: drilona@mskcc.org.
  • Lin JJ; Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Filleron T; Department of Medicine, Oncopole University Cancer Institute, Toulouse, France.
  • Ni A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Milia J; Department of Medicine, France Larrey Center University Hospital Toulouse, Toulouse, France.
  • Bergagnini I; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hatzoglou V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Velcheti V; Department of Medicine, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.
  • Offin M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Li B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Carbone DP; Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Besse B; Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Mok T; Department of Medicine, Chinese University of Hong Kong, Hong Kong, China.
  • Awad MM; Department of Medicine, Dana Farber Cancer Institute, Cambridge, MA.
  • Wolf J; Department of Medicine, Lung Cancer Group Cologne, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Owen D; Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Camidge DR; Department of Medicine, University of Colorado-Denver, Aurora, CO.
  • Riely GJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Peled N; Department of Medicine, Davidoff Cancer Center, Petah Tikva, Israel.
  • Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Mazieres J; Department of Medicine, Oncopole University Cancer Institute, Toulouse, France.
  • Gainor JF; Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Gautschi O; Department of Medicine, Cantonal Hospital Lucerne, Luzern, Switzerland.
J Thorac Oncol ; 13(10): 1595-1601, 2018 10.
Article em En | MEDLINE | ID: mdl-30017832
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Inibidores de Proteínas Quinases / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article